Clinical Trials Directory

Trials / Unknown

UnknownNCT00885404

Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation

A Prospective, Before and After Study of the Impact of Lower Chloride Intravenous Fluid Management on Patients' Acid-base Status, Renal Profile,Length of Stay and Mortality.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
7,000 (estimated)
Sponsor
Austin Health · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether intravenous fluid management using lower chloride solutions (Hartmann's solutions and Plasmalyte®) will result in better outcome when compared to management using high chloride solutions (0.9% saline and Gelofusine®).

Detailed description

This is a prospective, controlled, before-and-after study. The baseline pre-intervention period will include collection of data while doctors and nurses are unaware that such collection is taking place. During this time, high chloride fluids (saline, Gelofusine, 4% albumin) will continue to be used according to standard practice with an estimated 30,000 liters of saline as well as 2,000 bottles of Gelofusine® being consumed. Following a wash out period of education and preparation, there will be a complete shift to a working environment where use of saline, Gelofusine and any other fluids with a high chloride level (\>110 mmol/L)will be restricted and substituted with fluids of lower chloride concentration similar to blood; either Hartmann's solution or Plasmalyte® or 20% albumin. The study will compare a 6 month control period (before) and a six month intervention period (after).

Conditions

Interventions

TypeNameDescription
DRUGLower chloride fluids (Hartmann's solution and Plasmalyte®)Intravenous fluids used during the 6 month intervention period (after). Amount of fluids to be used is based on clinicians' discretion.

Timeline

Start date
2009-02-01
Primary completion
2009-08-01
Completion
2010-08-01
First posted
2009-04-22
Last updated
2010-02-25

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00885404. Inclusion in this directory is not an endorsement.